In vivo experiments showed that intravenous injections of anti-CXCR 4 siRNA not only decreased the CXCR4 mRNA level to 10% of the control level, but also virtually blocked metastasis into the lungs [159] and suppressed the primary tumor growth [223]. Here, CXCR4 is linked to neoplasm.